Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Richard M. Tjon Joe Gin"'
1
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial
Autor: Richard M. Tjon Joe Gin, Emanuele Barbato, Thomas O. Bergmeijer, Arnoud W J van 't Hof, Pim W. M. van Dorst, Daniel M.F. Claassens, Arend Mosterd, Vera H.M. Deneer, Renicus S Hermanides, Carmine Morisco, Folkert W. Asselbergs, Willem Dewilde, Gerrit J.A. Vos, C. Boersma, Pim van der Harst, Jean-Paul R. Herrman, Jurriën M. ten Berg, Maarten J. Postma
Publikováno v: American Journal of Cardiovascular Drugs, 22(2), 195-206. Adis International Ltd
American journal of cardiovascular drugs, 22(2), 195-206. ADIS INT LTD
INTRODUCTION: The POPular Genetics trial demonstrated that a CYP2C19 genotype-guided P2Y12 inhibitor strategy reduced bleeding rates compared with standard treatment with ticagrelor or prasugrel without increasing thrombotic event rates after primary
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::524e9c700d35d5b49880db1ea1289396
http://hdl.handle.net/11588/857926
Zobrazit plný text záznamu
2
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial
Autor: Daniel M F, Claassens, Pim W M, van Dorst, Gerrit J A, Vos, Thomas O, Bergmeijer, Renicus S, Hermanides, Arnoud W J, van 't Hof, Pim, van der Harst, Emanuele, Barbato, Carmine, Morisco, Richard M, Tjon Joe Gin, Folkert W, Asselbergs, Arend, Mosterd, Jean-Paul R, Herrman, Willem J M, Dewilde, Maarten J, Postma, Vera H M, Deneer, Jurriën M, Ten Berg, Cornelis, Boersma
Publikováno v: American journal of cardiovascular drugs : drugs, devices, and other interventions. 22(2)
The POPular Genetics trial demonstrated that a CYP2C19 genotype-guided P2YIn this analysis, we aimed to evaluate the cost effectiveness of a genotype-guided strategy compared with standard treatment with ticagrelor or prasugrel.A 1-year decision tree
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2efc2d844eddc5888d596f5b53a046e3
https://pubmed.ncbi.nlm.nih.gov/34490590
Zobrazit plný text záznamu
3
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype A POPular Genetics Subanalysis
Autor: Vera H.M. Deneer, Renicus S Hermanides, Carmine Morisco, Richard M. Tjon Joe Gin, Gerrit J.A. Vos, Arend Mosterd, Pim van der Harst, Daniel M.F. Claassens, Jean-Paul R. Herrman, Johannes C. Kelder, Willem Dewilde, Paul W.A. Janssen, Bakhtawar K. Mahmoodi, Arnoud W J van 't Hof, Jurriën M. ten Berg, Folkert W. Asselbergs, Thomas O. Bergmeijer, Emanuele Barbato
Publikováno v: Circulation-Cardiovascular interventions, 14(4):009434, 402-411. LIPPINCOTT WILLIAMS & WILKINS
Circulation. Cardiovascular interventions, 14(4). Lippincott Williams and Wilkins
Circulation: Cardiovascular Interventions, 14(4), 402. Lippincott Williams and Wilkins Ltd.
Circulation-Cardiovascular Interventions, 14(4):009434, 402-411. LIPPINCOTT WILLIAMS & WILKINS
Background: Guidelines favor ticagrelor or prasugrel over clopidogrel in patients with myocardial infarction. However, the POPular Genetics trial (Patient Outcome After Primary Percutaneous Coronary Intervention [PCI]) showed that in patients with pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54ef6016a26fcea7ac724e7cf6c3723
https://research.rug.nl/en/publications/c88d7bed-0522-46be-abfa-3331f07b3fe4
Zobrazit plný text záznamu
5
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients
Autor: Michiel Voskuil, J. Wouter Jukema, Arnoud W J van 't Hof, Ton Heestermans, Gerrit J.A. Vos, Pim van der Harst, Richard M. Tjon Joe Gin, Marieke E. Gimbel, Sjoerd H. Hofma, A. Mosterd, Clemens von Birgelen, Jurriën M. ten Berg, Evelyn A. de Vrey, Folkert W. Asselbergs, Emanuele Barbato, Vera H.M. Deneer, Renicus S Hermanides, Thomas O. Bergmeijer, Willem Dewilde, Jean-Paul R. Herrman, Carmine Morisco, Frank R. den Hartog, Daniel M.F. Claassens, Bakhtawar K. Mahmoodi, Reinier A. Waalewijn
Publikováno v: International Journal of Cardiology, 334, 10-17. Elsevier Ireland Ltd
International journal of cardiology, 334, 10-17. Elsevier Ireland Ltd
International Journal of Cardiology, 334, 10-17. ELSEVIER IRELAND LTD
International Journal of Cardiology, 334, 10. Elsevier Ireland Ltd.
Background: Patients with acute coronary syndrome (ACS) who are carrying CYP2C19 loss-of-function alleles derive less benefit from clopidogrel treatment. Despite this, in elderly patients, clopidogrel might be preferred over more potent P2Y12 inhibit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7cc27e8784270e89ec58851d8398315
https://hdl.handle.net/1874/415888
Zobrazit plný text záznamu
6
A Genotype-Guided Strategy for Oral P2Y
Autor: Daniel M F, Claassens, Gerrit J A, Vos, Thomas O, Bergmeijer, Renicus S, Hermanides, Arnoud W J, van 't Hof, Pim, van der Harst, Emanuele, Barbato, Carmine, Morisco, Richard M, Tjon Joe Gin, Folkert W, Asselbergs, Arend, Mosterd, Jean-Paul R, Herrman, Willem J M, Dewilde, Paul W A, Janssen, Johannes C, Kelder, Maarten J, Postma, Anthonius, de Boer, Cornelis, Boersma, Vera H M, Deneer, Jurriën M, Ten Berg
Publikováno v: The New England journal of medicine. 381(17)
It is unknown whether patients undergoing primary percutaneous coronary intervention (PCI) benefit from genotype-guided selection of oral P2YWe conducted a randomized, open-label, assessor-blinded trial in which patients undergoing primary PCI with s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7dfca0cfc958706907f69880eadf21ef
https://pubmed.ncbi.nlm.nih.gov/31644850
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje